Ontology highlight
ABSTRACT:
SUBMITTER: Cavallari LH
PROVIDER: S-EPMC5558508 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature
Pharmacogenomics 20170327 5
The University of Florida (UF) Health Personalized Medicine Program launched in 2012 with CYP2C19 genotyping for clopidogrel response at UF Health Shands Hospital. We have since expanded CYP2C19 genotyping to UF Health Jacksonville and established the infrastructure at UF Health to support clinical implementation for five additional gene-drug pairs: TPMT-thiopurines, IFNL3 (IL28B)-PEG IFN-α-based regimens, CYP2D6-opioids, CYP2D6/CYP2C19-antidepressants and CYP2C19-proton pump inhibitors. We are ...[more]